NCT07211282 Monitoring and Guidance of Physical Activity During the Maintenance Phase of Cardiac Rehabilitation: the Antwerp Activity Index
| NCT ID | NCT07211282 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Antwerp |
| Condition | Cardiac Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 318 participants |
| Start Date | 2025-02-17 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 318 participants in total. It began in 2025-02-17 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine whether the AAI activity score can help cardiac rehabilitation patients adhere to physical activity guidelines after participating in an in-hospital cardiac rehabilitation program. The main questions it aims to answer are: 1. Does the AAI activity score have an impact on adherence to physical activity maintenance during phase 3 CR? 2. Does the AAI activity score predict changes in cardiorespiratory fitness? Researchers will compare participants who use the AAI activity score with those who do not to determine if there are differences in physical activity adherence. Participants will: * Wear a smartwatch to continuously measure heart rate for 4 months; * Perform an exercise stress test at the end of the study; * Fill in several questionnaires at the end of the study.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years, 2. Patients in the last phase of phase 2 CR, 3. Having a smartphone available, 4. Being capable of signing the informed consent. Exclusion Criteria: 1. Patients with high-risk criteria for safe exercise participation following a cardiac event, including: 1. Ejection fraction less than 30% 2. Decrease in systolic blood pressure of more than 15 mmHg with exercise 3. Serious arrhythmias at rest or exercise-induced 4. Exercise-induced ischemia indicated by angina more than 2 mm ST segment depression on the ECG 2. Patients with severe heart failure (NYHA III-IV), 3. Patients with implantable devices (e.g. pacemakers), 4. Patients diagnosed with permanent AF, 5. Patients who do not speak and read Dutch or English, 6. Patients who have cognitive impairment (e.g. severe dementia).
Contact & Investigator
Hein Heidbuchel
PRINCIPAL INVESTIGATOR
University Hospital, Antwerp
Frequently Asked Questions
Who can join the NCT07211282 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07211282 currently recruiting?
Yes, NCT07211282 is actively recruiting participants. Contact the research team at christophe.buyck@uantwerpen.be for enrollment information.
Where is the NCT07211282 trial being conducted?
This trial is being conducted at Edegem, Belgium, Hasselt, Belgium.
Who is sponsoring the NCT07211282 clinical trial?
NCT07211282 is sponsored by University Hospital, Antwerp. The principal investigator is Hein Heidbuchel at University Hospital, Antwerp. The trial plans to enroll 318 participants.